1. Home
  2. BOLD vs AWRE Comparison

BOLD vs AWRE Comparison

Compare BOLD & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • AWRE
  • Stock Information
  • Founded
  • BOLD 2018
  • AWRE 1986
  • Country
  • BOLD United States
  • AWRE United States
  • Employees
  • BOLD N/A
  • AWRE N/A
  • Industry
  • BOLD
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • BOLD
  • AWRE Technology
  • Exchange
  • BOLD Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • BOLD 30.3M
  • AWRE 34.6M
  • IPO Year
  • BOLD 2024
  • AWRE 1996
  • Fundamental
  • Price
  • BOLD $1.07
  • AWRE $1.83
  • Analyst Decision
  • BOLD Buy
  • AWRE
  • Analyst Count
  • BOLD 3
  • AWRE 0
  • Target Price
  • BOLD $4.00
  • AWRE N/A
  • AVG Volume (30 Days)
  • BOLD 363.5K
  • AWRE 52.0K
  • Earning Date
  • BOLD 08-11-2025
  • AWRE 08-07-2025
  • Dividend Yield
  • BOLD N/A
  • AWRE N/A
  • EPS Growth
  • BOLD N/A
  • AWRE N/A
  • EPS
  • BOLD N/A
  • AWRE N/A
  • Revenue
  • BOLD N/A
  • AWRE $16,576,000.00
  • Revenue This Year
  • BOLD N/A
  • AWRE N/A
  • Revenue Next Year
  • BOLD N/A
  • AWRE N/A
  • P/E Ratio
  • BOLD N/A
  • AWRE N/A
  • Revenue Growth
  • BOLD N/A
  • AWRE N/A
  • 52 Week Low
  • BOLD $1.00
  • AWRE $1.35
  • 52 Week High
  • BOLD $4.72
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • AWRE 55.37
  • Support Level
  • BOLD N/A
  • AWRE $1.78
  • Resistance Level
  • BOLD N/A
  • AWRE $1.93
  • Average True Range (ATR)
  • BOLD 0.00
  • AWRE 0.15
  • MACD
  • BOLD 0.00
  • AWRE -0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • AWRE 22.95

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: